| PERIOD ENDING | 31-Dec-01 | 31-Dec-00 | 31-Dec-99 | | Total Revenue | 1,143 | 962 | 543 | | Cost of Revenue | 1,044 | 729 | 332 | | | Gross Profit | 99 | 232 | 211 | | | Operating Expenses | | Research Development | 2,483 | 1,780 | 842 | | Selling General and Administrative | 7,242 | 5,726 | 2,870 | | Non Recurring |
-
|
-
|
-
| | Others | 285 | 235 | 65 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,910) | (7,508) | (3,566) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18 | (99) | (21) | | Earnings Before Interest And Taxes | (9,892) | (7,607) | (3,587) | | Interest Expense | 50 | 47 |
-
| | Income Before Tax | (9,942) | (7,654) | (3,587) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest | 11 |
-
|
-
| | | | Net Income From Continuing Ops | (9,930) | (7,654) | (3,587) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (9,930) | (7,654) | (3,587) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,930) | ($7,654) | ($3,587) |
|
0.47% Nasdaq 0.00%
Income Statement
